Evidence map›Paper›PMID 41055390›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Enantioselective Synthesis of α-Arylated Allene Ketones Through Sequential Bismuth(V)-mediated Arylation and Organocatalytic Protonation.

Kun Zhu, Yuli Sun, Yunhan Ma, Zugen Wu, Yixin Lu

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kun ZhuDepartment of Chemistry, National University of Singapore, Singapore, 117543, Singapore.
Yuli SunDepartment of Chemistry, National University of Singapore, Singapore, 117543, Singapore.
Yunhan MaDepartment of Chemistry, National University of Singapore, Singapore, 117543, Singapore.
Zugen WuDepartment of Chemistry, National University of Singapore, Singapore, 117543, Singapore.
Yixin LuDepartment of Chemistry, National University of Singapore, Singapore, 117543, Singapore.ORCID https://orcid.org/0000-0002-5730-166X

Funding

Ministry of Education (MOE) of Singapore A-0008481-00-00National University of Singapore A-8001466-00-00
6 · The paper itself

Abstract

Triarylbismuth(V)-mediated arylation represents an important approach for synthesizing a wide range of α-arylated ketones and enol derivatives. Since the seminal work by Barton and colleagues in the 1980s, these C─C bond-forming transformations have been extensively explored. Despite significant progress, asymmetric variants of these reactions have yet to be developed. In this study, we document a sequential reaction consisting of bismuth-mediated α-arylation of allene ketones and an enantioselective protonation of α-arylated alkynyl ketones, leveraging the isomerization between allenyl and alkynyl intermediates. Our approach relies on a reversible/irreversible isomerization sequence comprising three distinct stages. The process initiates with the generation of enolates through reversible isomerization, followed by oxidative arylation and a subsequent enantioselective, irreversible isomerization to yield α-arylated allenones. Both experimental results and theoretical studies support our mechanistic proposal. The sequential bismuth(V)-mediated arylation and enantioselective proton transfer is conceptually significant, as coupling bismuth chemistry with asymmetric catalysis may open new avenues for organobismuth(V) chemistry in enantioselective transformations and extend its utility in synthetic organic chemistry.

Indexed as

Asymmetric ArylationBismuthChiral AllenonesEnantioselectivityOrganocatalysis

Identifiers

PMID41055390
PMCPMC12643346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.